Orchestra

Orchestra

Private
San Francisco, CaliforniaEnterprise Softwarehttps://orchestra.bio/

Last Round

Debt

Apr 1, 2026

Total Funding Raised

$20M

Momentum Score

25 /100

Company Overview

Orchestra is a business/productivity software company that has developed a life sciences R&D management platform designed to optimize the planning, execution, and monitoring of complex drug development programs.

Sector

Enterprise Software

Verticals

Vertical SaaS, Biotechnology, Project Management, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

biotech R&D platformdrug development softwareR&D OSlife sciences softwareR&D planningbiotech project managementR&D financefinancial modelingscenario modelingdrug discovery softwareAI-powered risk trackingAI knowledge basevertical SaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Orchestra Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Orchestra Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
DebtApr 1, 2026
SeedAug 1, 2025

Key People

Founding team and executive leadership

Ashoka Rajendra

CEO

Executive Team

Andy Xu

Chief Technology Officer

Executive Team

Orchestra Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 1, 2026

    $20M debt round completed.

  • Aug 1, 2025

    $20M raised with participation from Andreessen Horowitz and 8VC.

Orchestra Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Orchestra Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Orchestra's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range17
Year Founded2022
Last FundingApr 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.